Odor is a common reason users reject disposable medical masks even when filtration, breathability, and appearance meet the required specification. Complaints are usually described as “chemical,” “plastic,” “ink,” “musty,” or simply “strong smell after opening.”

For hospitals, distributors, and OEM medical mask programs, odor should not be treated only as a comfort issue. A noticeable smell can indicate differences in raw materials, packaging, sterilization, storage, or production control. It can also create repeated complaints when a new production lot feels different from the approved sample.

Reducing odor problems therefore starts with identifying where the odor is coming from.

1. Check the Nonwoven Raw Materials

Most disposable medical masks are made from several polypropylene-based nonwoven layers, commonly including spunbond and meltblown materials.

Fresh polymer materials can have a mild characteristic smell, but unusually strong odor may indicate differences in:

• Raw-material formulation
• Processing temperature
• Additives
• Masterbatch
• Recycled or contaminated material
• Storage conditions before mask production

For medical mask production, changing the nonwoven supplier or material grade without reviewing the finished mask can create a noticeable difference in odor even when basis weight and appearance remain similar.

For repeat OEM orders, the approved nonwoven specification should therefore be maintained together with filtration and weight requirements.

2. Pay Attention to Color Masterbatch and Additives

Blue, green, pink, black, and customized masks may require pigments or masterbatch in the outer nonwoven layer.

The color itself is usually not the problem. The issue is whether the pigment system and other additives are suitable for the intended product and consistently processed.

If a new color produces stronger odor than the standard white or blue version, compare the colored raw material separately.

For an OEM project, it is useful to approve the final colored mask rather than approving the structure in white and assuming that changing color will have no effect on user experience.

3. Review Packaging Ink and Printing

Sometimes users believe the mask itself smells when the odor actually originates from the packaging.

Printed film, dispenser boxes, labels, and individual pouches may contain inks, coatings, adhesives, or other packaging materials that release noticeable volatile compounds after printing.

The risk is greater when finished masks are packed immediately after newly printed packaging is produced.

Possible complaints include:

• Solvent-like smell
• Ink smell
• Plastic-film smell
• Odor that is stronger inside the sealed bag than on the mask after airing

For private-label medical masks, packaging samples should therefore be evaluated together with the product.

If odor appears only after switching to customized packaging, the mask material may not be the source.

4. Allow Packaging Materials to Cure Before Packing

Printed packaging may require sufficient curing or airing time before it contacts the finished product.

Packing too soon can trap residual odors inside sealed bags or boxes. Those odors can then transfer to the mask during storage and become noticeable immediately when the package is opened.

For OEM production, this is especially relevant when:

• New artwork is introduced
• A different printing supplier is used
• Ink coverage becomes heavier
• Laminated packaging is changed
• Individual sealed packs replace bulk dispenser-box packing

An odor check should therefore be performed on finished packed samples, not only on unpacked masks from the production line.

5. Control EO Sterilization Residuals Where EO Is Used

Some medical masks are supplied sterile and may use ethylene oxide sterilization.

When EO sterilization is used, residual sterilant must be controlled through a validated sterilization and aeration process. ISO 10993-7:2026 specifies allowable limits and methods for evaluating residual EO and ethylene chlorohydrin in EO-sterilized medical devices.

A strong chemical odor after opening should therefore not simply be dismissed as “normal because the mask is sterile.”

For EO-sterilized products, review:

• Validated sterilization cycle
• Aeration time
• Product release criteria
• EO residual testing
• Packaging material
• Time between sterilization and shipment

It is important to distinguish odor perception from regulatory residual testing. Smell alone cannot determine whether EO residues meet applicable limits, so analytical testing should be used where required.

Rayland Medical's current Type II mask specification lists EO sterilization as the standard sterile option, making sterilization and storage conditions relevant parameters when reviewing the finished product.

6. Do Not Shorten Aeration Only to Accelerate Delivery

When an order is urgent, shortening post-sterilization handling time can create unnecessary risk.

EO-sterilized products require adequate aeration according to the validated process before release. ISO 10993-7:2026 specifically includes product-release approaches based on minimum aeration time and residual dissipation.

For procurement teams, a shorter quoted lead time is not necessarily better if it creates complaints after cartons are opened.

When sterile masks are ordered, confirm whether the quoted production time includes sterilization, aeration, testing, and release rather than only mask manufacturing.

7. Prevent Odor Transfer During Storage

Nonwoven masks and packaging materials can pick up surrounding odors if they are stored close to substances with strong smells.

Finished masks should not share poorly controlled warehouse space with chemicals, fuels, strong cleaning agents, fragranced products, or other odor-emitting materials.

Rayland Medical's Type II product information specifies storage in a dry, well-ventilated warehouse away from toxic or corrosive substances, with defined temperature and humidity conditions.

The same principle should continue during:

• Factory storage
• Forwarder warehousing
• Container loading
• Importer storage
• Distributor fulfillment

If the masks leave the factory without odor but complaints appear after long-distance transport, storage and logistics should also be investigated.

8. Check Container Conditions Before Shipment

International shipments may remain inside containers for several weeks.

High temperature can increase the release of odors from plastics, printing inks, adhesives, and other packaging materials. A container with previous cargo odors can also contaminate cartons.

Before loading a large medical mask shipment, check that the container is:

• Dry
• Clean
• Free from strong odor
• Free from chemical residue
• Suitable for medical-product packaging

Odor complaints that appear only in export orders but not in domestic samples can sometimes be traced to the logistics stage rather than mask production.

9. Compare the Finished Mask After Sealed Storage

Fresh production-line samples do not always reproduce what users experience.

A mask may have little odor immediately after production but develop a stronger enclosed smell after several days inside sealed packaging.

For OEM approval, keep several finished packs sealed and evaluate them after a defined storage period.

A practical comparison can include:

Immediately after packing
After several days
After simulated warm storage
After transport simulation

The purpose is not to invent a new regulatory odor test, but to reproduce the conditions under which the customer will actually open the product.

10. Establish a Reference Sample for Odor

Odor perception is subjective, which makes complaints difficult to investigate unless there is a reference.

For recurring orders, retain samples from an accepted batch.

If a later shipment receives complaints, compare:

• Raw material lot
• Packaging
• Printing
• Sterilization lot
• Production date
• Storage duration
• Odor of the retained sample and new lot

A simple internal sensory inspection performed under consistent conditions can help identify an obvious production change.

If a chemical-residual concern exists, laboratory analysis should be used rather than relying on sensory assessment alone.

11. Do Not Add Fragrance to Hide the Problem

Adding fragrance may make a mask smell more pleasant initially, but it is generally the wrong solution for a medical product unless the product has specifically been designed, evaluated, and documented for such use.

Fragrance introduces another substance close to the user's nose and skin and may create new complaints about irritation or sensitivity.

The better approach is to remove the source of an abnormal odor rather than cover it.

What to Include in an OEM Mask Specification

For projects where odor consistency matters, the purchase specification can control more than BFE and differential pressure.

Useful points include:

• Approved nonwoven materials
• Material basis weight
• Color/masterbatch
• Packaging material
• Printing specification
• Sterilization method
• EO residual requirement where applicable
• Storage conditions
• Approved finished-product sample
• Requirement for no abnormal or objectionable odor

Rayland Medical supplies Type I, Type II and Type IIR disposable medical masks and can review mask construction, packaging, sterilization and destination-market requirements before bulk production.

Find the Odor Source Before Changing the Mask

Reducing odor complaints does not necessarily require changing the entire mask construction.

The source may be the nonwoven material, pigment, packaging ink, sterilization process, insufficient aeration, warehouse environment, or shipping container.

The most effective approach is to compare the complained-about lot with an approved lot and trace what changed.

For OEM disposable masks, controlling raw materials and packaging while evaluating the product after sterilization, sealing, storage, and transport provides a much more realistic picture of what the end user will experience when the package is opened.